# IRINOTECAN HYDROCHLORIDE
> **ANDA203054** · Abbreviated New Drug Application (Generic) · Sponsor: INTAS PHARMS USA · Approved 2017-08-31
## Drug
- **FDA Application Number:** ANDA203054
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** IRINOTECAN HYDROCHLORIDE
- **Generic name:** Irinotecan Hydrochloride
- **Active ingredients:** IRINOTECAN HYDROCHLORIDE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** INTAS PHARMS USA
- **First approval:** 2017-08-31
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203054)
---
*MORVS · CC0 1.0*